Taani - taani - Lægemiddelstyrelsen (Danish Medicines Agency)

2care4 aps - cyclophosphamid, vandfrit - overtrukne tabletter - 50 mg

Taani - taani - Lægemiddelstyrelsen (Danish Medicines Agency)

2care4 aps - cyclophosphamid, vandfrit - pulver til injektionsvæske, opløsning - 1 g

Euroopa Liit - taani - EMA (European Medicines Agency)

csl behring gmbh - human koagulationsfaktor viii, menneskelige von willebrand faktor - hemophilia a; von willebrand diseases - blood coagulation factors, von willebrand factor and coagulation factor viii in combination, antihemorrhagics - von willebrand sygdom (vwd)profylakse og behandling af blødning eller kirurgisk blødning i patienter med vwd, når desmopressin (ddavp) behandlingen alene er ineffektive eller kontraindiceret. hæmofili a (medfødt faktor viii-mangel)profylakse og behandling af blødning hos patienter med hæmofili a.

Taani - taani - Lægemiddelstyrelsen (Danish Medicines Agency)

baxter a/s - cyclophosphamid, vandfrit - overtrukne tabletter - 50 mg

Taani - taani - Lægemiddelstyrelsen (Danish Medicines Agency)

baxter a/s - cyclophosphamid, vandfrit - pulver til injektionsvæske, opløsning - 200 mg

Euroopa Liit - taani - EMA (European Medicines Agency)

mylan ire healthcare limited - bevacizumab - colorectal neoplasms; breast neoplasms; ovarian neoplasms; fallopian tube neoplasms; peritoneal neoplasms; carcinoma, non-small-cell lung; carcinoma, renal cell; uterine cervical neoplasms - antineoplastiske midler - treatment of carcinoma of the colon or rectum, breast cancer, non-small cell lung cancer, renal cell cancer, epithelial ovarian, fallopian tube or primary peritoneal cancer, and carcinoma of the cervix.

Taani - taani - Lægemiddelstyrelsen (Danish Medicines Agency)

2care4 aps - cyclophosphamid, vandfrit - pulver til injektionsvæske, opløsning - 200 mg

Euroopa Liit - taani - EMA (European Medicines Agency)

merck sharp & dohme b.v.  - imipenem, monohydrat, cilastatin natrium, relebactam monohydrat - gram-negative bakterie-infektioner - carbapenems, antibacterials for systemic use, - recarbrio is indicated for:- treatment of hospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap), in adults (see sections 4. 4 og 5. - treatment of bacteraemia that occurs in association with, or is suspected to be associated with hap or vap, in adults. - treatment of infections due to aerobic gram-negative organisms in adults with limited treatment options (see sections 4. 2, 4. 4 og 5. det bør overvejes at officielle vejledning om hensigtsmæssig brug af antibakterielle midler..

Taani - taani - SEGES Landbrug & Fødevarer

scotts celaflor handelsgesellschaft mbh - dicamba, 2,4-d - granulat - 1,2 g/kg dicamba ; 8 g/kg 2,4-d

Taani - taani - SEGES Landbrug & Fødevarer

scotts celaflor handelsgesellschaft mbh - acetamiprid - granulat - 40 g/kg acetamiprid